A wide array of voices from across the country are calling on lawmakers to oppose recently reintroduced legislation, the Pharmacy Benefit Manager Transparency Act (S.127), which fundamentally misconstrues the role of pharmacy benefit companies, unfairly proposes to take away employers’
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on S. 1388, the “Prescription Drug Pricing for the People Act.” PCMA, the trade association for America’s pharmacy benefit managers (PBMs), today endorsed S. 1388, the “Prescription
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on a new white paper issued by the Institute for Clinical and Economic Review (ICER), “Assessment of Barriers to Fair Access:” “We appreciate ICER’s
The Pharmaceutical Care Management Association (PCMA) – the national association representing America’s pharmacy benefit managers is seeking a Senior Director, Conferences responsible for managing all aspects of conference planning and logistics. This position reports to the Chief Strategy & Business Operations Officer.
(Washington, D.C.) — The Pharmaceutical Supply and Payment Chain Coalition issued the following statement in response to the Administration’s 100-day review of the actions needed to address vulnerabilities in our nation’s pharmaceutical supply chain and what measures need to be taken in order
PBMs leverage competition between drugs to create savings for patients.
Florida-based Newtek Business Solutions is a business development company that helps small and midsize businesses run their operations. Newtek serves the IT, HR, financial and customer service needs of their 100,000 customers. Newtek is a publicly traded company that has
May is Asthma Awareness Month, and today – May 5 – is World Asthma Day. The Asthma and Allergy Foundation of America is marking the day with the release of their 2021 Asthma Capitals Report.
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the reported “counteroffer” by the pharma lobby to the Administration: “While we remain deeply engaged in seeking solutions to lower drug prices
©2024 PCMA. All Rights Reserved.
